This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Cramer's Action Alerts PLUS - See his portfolio and get alerts BEFORE every trade. Learn more NOW!

Xerium Sales And Adjusted EBITDA Increase In Q3 2013

Xerium Technologies, Inc. (NYSE: XRM), a leading global provider of industrial consumable products and services, today announced its Q3 2013 results.

Key Highlights

* Sales continue to increase:

  • On a constant currency basis, Q3 2013 sales increased 0.2% from Q3 2012. See “Segment Information” and “Non-GAAP Financial Measures” below for further discussion.
  • Q3 2013 sales per employee were $171k, remaining at a four year high.
  • Backlog at September 30, 2013 was $156 million, slightly down from backlog at June 30, 2013, but consistent with seasonal expectations regarding orders.
  • 2013 September Year-To-Date (YTD) sales were $413.2 million. Excluding foreign currency effects, YTD sales increased $9.1 million, or 2.2%, versus the comparable prior year period. This sales growth is in line with global paper market trade group estimates.
    • Excluding foreign currency effects, sales increased across all regions, $4.2 million or 5.5% in Asia, $2.8 million or 2.0% in Europe and $2.1 million or 1.1% in the Americas.

    • Constant currency sales growth was higher in rolls & mechanical services at $5.7 million, or 4.1%, than in machine clothing, which grew $3.4 million, or 1.3%.
    • Sales growth continues to be hampered by lack of production capacity in multiple product areas. The Company is progressively working to eliminate these bottlenecks.
  • For the last twelve months, sales and orders are exactly balanced on a constant currency basis at $542.2 million.

* Adjusted EBITDA continues to increase:

  • Q3 2013 Adjusted EBITDA was $27.2 million, or 20.2% of sales. This is an increase of $2.8 million or 11.5% versus Q3 2012. See "Non-GAAP Financial Measures" below.
  • September 2013 YTD Adjusted EBITDA was $83.3 million. This is an increase of $14.6 million or 21% over the comparable prior year period.
  • Sales growth accounts for 27% and net cost reduction accounts for 73% of the September 2013 YTD Adjusted EBITDA improvement.
  • SG&A continues to trend lower in both dollars and percentage. The improvement is primarily driven by cost reduction programs.
  • Gross profit and gross margin continue to trend higher. The improvement is primarily driven by cost reduction programs.

* Additional cost reduction programs continue to be implemented:

  • Compared to last year, cost reduction programs delivered an incremental $7.0 million in Q3 and an incremental $18.0 million through September 2013. This compares to $5.4 million in Q1 2013 and $5.6 in Q2 2013.
  • Plant efficiency programs (waste reduction, procurement programs, productivity and logistics programs) account for approximately 40% of the YTD cost reduction improvements while restructuring programs account for 60% of the YTD cost reduction improvements.
  • In Q3, Xerium announced plans to build a new, high-end press felt plant near Shanghai, China. This is anticipated to deliver both cost reduction and sales growth results.
  • In Q3, the Company identified its restructuring goals targeted for implementation in Q1 2014.

* The Company continues to reinvest the majority of its free cash flow to improve future results by:

  • Ordering long lead time equipment;
  • Making restructuring/severance payments;
  • Finishing 4 plant closures, while 7 plant expansions are currently underway;
  • Initiating the next plant closure;
  • Building the new greenfield plant in China;
  • Expanding the Company's after-market rolls and service footprint and capabilities;
  • Implementing 10 new product programs that open new market aperture for Xerium to grow sales in the future; and
  • Lowering its net debt to $394.4 million. Net debt leverage continues to improve in line with Adjusted EBITDA improvements, declining to approximately 3.8x Adjusted EBITDA.

* Q3 fully diluted earnings per share grew from a net loss of $(0.24) per diluted share to net income of $0.13 per diluted share, primarily as a result of increased gross margins and decreased operating expenses as a result of our cost reduction initiatives.

1 of 8

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Try it NOW
Only $9.95
Try it NOW
14-Days Free
Try it NOW

Check Out Our Best Services for Investors

Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Options Profits

Our options trading pros provide over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • Actionable options commentary and news
  • Real-time trading community
Try it NOW
Try it NOW
Try it NOW
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!
SYM TRADE IT LAST %CHG

Markets

DOW 18,132.70 -81.72 -0.45%
S&P 500 2,104.50 -6.24 -0.30%
NASDAQ 4,963.5270 -24.3630 -0.49%

Partners Compare Online Brokers

Free Reports

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs